Related Experiment Video
Updated: Aug 23, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Prevention of restenosis after coronary angioplasty
Ganesan Karthikeyan1, Balram Bhargava
1Department of Cardiology, Cardiothoracic Sciences Center, All India Institute of Medical Sciences, New Delhi, India.
Insights
Drug-eluting stents significantly lower restenosis rates but carry high costs. Careful patient selection and judicious use of these stents, alongside traditional methods, optimize outcomes for coronary artery disease.
Area of Science:
- Interventional Cardiology
- Cardiovascular Research
- Biomedical Engineering
Background:
- Restenosis remains a significant challenge in coronary interventions despite technological advancements.
- The increasing use of drug-eluting stents necessitates a critical evaluation of current interventional strategies.
Purpose of the Study:
- To critically reexamine the roles of various interventional techniques in light of drug-eluting stent usage.
- To assess the effectiveness and cost-benefit of different approaches to managing coronary artery disease.
Main Methods:
- Review of current literature on coronary interventions, focusing on drug-eluting stents, bare metal stents, and angioplasty.
- Analysis of factors influencing restenosis and target vessel revascularization.
- Evaluation of cost implications and patient selection criteria.
Main Results:
- Drug-eluting stents substantially reduce restenosis and revascularization rates across diverse patient groups and lesion types.
- Restenosis, when it occurs with drug-eluting stents, is influenced by factors similar to those seen with bare metal stenting.
- Debulking techniques have not met expectations for improving angioplasty outcomes; gene therapy shows promise for reducing neointimal proliferation.
Conclusions:
- Optimizing angioplasty outcomes with drug-eluting stents requires careful patient selection and precise stent deployment.
- Cost-effectiveness suggests reserving drug-eluting stents for patients with the greatest potential absolute benefit.
- Conventional balloon angioplasty and bare metal stenting retain a valuable role in managing obstructive coronary artery disease when used judiciously.
Purpose Of Review:
Despite numerous advances in coronary interventional techniques, the frequent occurrence of restenosis continues to plague interventional cardiology. With the widespread use of drug-eluting stents, there is a need to reexamine critically the roles of the various interventional techniques currently available.
Recent Findings:
Drug-eluting stents have dramatically reduced the rates of restenosis and target vessel revascularization in a wide spectrum of patients with varying lesion morphologies. However, when restenosis does occur, it still tends to be dependent on the same factors that predict restenosis with bare metal stenting. The routine use of drug-eluting stents entails high initial costs to the health care system. Debulking as a means to improve outcomes after angioplasty has not lived up to expectations. Gene therapy is rapidly evolving into a viable means to reduce neointimal proliferation after angioplasty.
Summary:
Careful patient selection and attention to the procedure of stent deployment optimize the results of angioplasty with drug-eluting stents. Because of cost considerations, drug-eluting stents should be used in patients who are expected to have the greatest absolute benefit. In this context, when judiciously used, conventional balloon angioplasty and bare metal stenting still have a definite role in the management of patients with obstructive coronary artery disease.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management
01:20Angina V: Nursing Management
01:23Peripheral Artery Disease V: Postoperative Nursing Management